The FDA approved leucovorin for treating cerebral folate deficiency but clarified there's insufficient evidence to support its use as an autism treatment, retracting previous statements suggesting broad benefits for autistic children. This decision underscores the importance of evidence-based claims in medical reporting and advises content creators to critically evaluate health information before dissemination.
Read the full article at STAT News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
11
Comments
Ali NematiWritten by Ali
